Circulating interleukin-6 type cytokines in patients with systemic lupus erythematosus

European Cytokine Network

Volumn 8, Issue 3, 1997, Pages 281-286

  Robak, Ewa ^a   Sysa Jȩdrzejowska, Anna ^a   Stȩpień, Henryk ^a   Robak, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Ciliary neurotrophic factor; Disease activity; Interleukin 6; Leukemia inhibitory factor; Oncostatin M; Systemic lupus erythematosus

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYTOKINE; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M;

ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CILIARY NEUROTROPHIC FACTOR; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; ONCOSTATIN M; PEPTIDES;

EID: 0030807922     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kishimoto T. 1990. The biology of interleukin-6. (Review) Blood 74: 1.
2. Kishimoto T. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. (Review) Science 258: 593.
3. Akira S, Taga T, Kishimoto T. 1993. Interleukin-6 in biology and medicine. (Review) Adv. Immunol. 54: 1.
4. Kishimoto T, Akira S, Narazaki M, Taga T. 1995. Interleukin-6 family of cytokines and gp130. (Review) Blood 86: 1243.
5. Hawley R G. 1994. Hematopathology of interleukin-6 type cytokines. (Review) Stem Cells 12 (suppl.1): 155.
6. Sprang S, Bazan J. 1993. Cytokine structural taxonomy and mechanism of receptor engagement. Curr. Opin. Struct. Biol. 3: 815.
7. Robinson R C, Grey L M, Staunton D, Vankelecom H, Vernallis A B, Moreau J F, Stuart D J, Heath J K, Jones E Y. 1994. The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell 77: 1101.
8. Taga T, Narazaki M, Yasukawa K, Saito D, Miki D, Hamagucki M, Davis S, Shoyab M, Yancopoulos G D, Kishimoto T. 1992. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin-6 signal transducer gp130. Proc. Natl. Acad. Sci USA 89: 10998.
9. Zhang X G, Gu J J, Lu Z Y, Yasukawa K, Yancopoulos G D, Turner K, Shoyab M, Taga T, Kishimoto T, Bataille R, Klein B. 1994. Ciliary neurotrophic factor, interleukin-11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin-6 signal transducer gp130. J. Exp. Med. 179: 1337.
10. Linker-Israeli M, Deans R J, Wallace D J, Prehn J, Ozeri-Chen T, Klinenberg J R. 1991. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J. Immunol. 147: 117.
11. Spronk P E, Borg E J, Limburg P C, Kallenberg C G. 1992. Plasma concentration of IL-6 in systemic lupus erythematosus: an indicator of disease activity? Clin. Exp. Immunol. 90: 106.
12. Robak E, Sysa-Jȩdrzejowska A, Robak T, Stȩpień H, Woźniacka A, Waszczykowska E. 1996. Tumour necrosis factor (TNF-α), interleukin-6 (IL-6) and their soluble receptors (sTNF-α Rp 55 and sIL-6R) serum levels in systemic lupus erythematosus. Mediators Inflamm. 5: 435.
13. Nagafuchi H, Suzuki N, Mizushima Y, Sakane T. 1993. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J. Immunol. 151: 6525.
14. Tan E M, Cohen A S, Fries J E, Masi A T, McShane D J, Rothfield N E, Schaller J G, Talal N, Winchester R J. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271.
15. Liang M H, Socher S A, Larson M G, Schur P H. 1989. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 32: 1107.
16. Swaak A J, Nossent J C, Smeenk R J. 1992. Systemic lupus erythematosus. (Review) Int. J. Clin. Lab. Res. 22: 190.
17. Tsokos G C. 1994. Lymphocytes, cytokines, inflammation and immune trafficking. (Review) Curr. Opin. Rheumatol. 6: 461.
18. Horwitz D A, Jacob C O. 1994. The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications. (Review) Springer Semin. Immunopathol. 16: 181.
19. Linker-Israeli M. 1992. Cytokine abnormalities in human lupus. (Review) Clin. Immunol. Immunopathol. 63: 10.
20. Handwerger B S, Rus V, da Silva L, Viv C S. 1994. The role of cytokines in the immunopathogenesis of lupus. (Review) Springer Semin. Immunopathol. 16: 153.
21. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot M C, Durand-Gasselin I, Fourrier B M, Galanaud P, Emilie D. 1993. Spontaneous production of interleukin-10 by B-lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Netw. 4: 421.
22. Meijer C, Huysen U, Smeenk R T J, Swaak A J. 1993. Profiles of cytokines (TNF-α and IL-6) and acute phase proteins (CRP and α 1AG) related to the disease course in patients with systemic lupus erythematosus. Lupus 2: 359.
23. al-Janadi M, al-Balla S, al-Dalaan A, Raziuddin S. 1993. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J Clin. Immunol. 13: 58.
24. Metsarinne K P, Nordstrom D C, Konttinen Y T, Teppo A M, Fyhrquist F Y. 1992. Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis and systemic lupus erythematosus. Rheumatol. Int. 12: 93.
25. Lorgeot V, Pralaran V, Turlure P, Demzot Y. 1997. Concentration of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies (letter). Leukemia 311.
26. Fixe P, Lorgeot V, Le Meur Y L, Coupey L, Heymann D, Godard A, Praloran V. 1996. Development of enzymo-immunoassays (EIA) for macrophage colony-stimulating factor (M-CSF) and leukemia inhibitory factor (LIF) by using the same capture and signal generating polyclonal antibody. Cytokine 8: 586.
27. Keller J R, Gooya J M, Ruscetti F W. 1996. Direct synergistic effects of leukemia inhibitory factor on hematopoietic progenitor cell growth: comparison with other hematopoietins that use the gp130 receptor subunit. Blood 88: 863.
28. Chevalier S, Fourcin M, Robledo D, Wijdenes J, Pouplard-Barthelaix A, Gascan H. 1996. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp 130 transducing protein. J. Biol. Chem. 271: 14764.
29. Gearing D P. 1993. The leukemia inhibitory factor and its receptor. (Review) Adv. Immunol. 53: 31.
30. Richards C D, Brown T J, Shoyab M, Baumann H, Gauldie J. 1992. Recombinant oncostatin M. stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J. Immunol. 148: 1731.
31. Espat N J, Auffenberg T, Rosenberg J J, Rogy M, Martin D, Fang C H, Hasseigren P O, Copeland E M, Moldawer L L. 1996. Ciliary neurotrophic factor is catabolic and shares with IL-6 the capacity to induce an acute phase response. Am. J. Physiol. 271 R: 185.
32. Hall A K, Rao M S. 1992. Cytokines and neurokines: related ligands and related receptors. (Review) Trends Neurosci 15: 35.
33. De Groote D, Fauchet F, Jadoul M, Dehart I, Raher S, Gevaert Y, Lopez M, Gathy R, Franssen J D, Radoux D, Franchimont P, Soulillou J P, Jacques Y, Godard A. 1994. An ELISA for the measurement of human leukemia inhibitory factor in biological fluids and culture supernatants J. Immunol. Methods 167: 253.
34. Takahashi R, Kawamura K, Hu J, Hayashi M, Deguchi T. 1996. Ciliary neurotrophic factor (CNTF) genotypes and CNTF contents in human sciatic nerves as measured by a sensitive enzyme-linked immunoassay. J. Neurochem. 67: 525.
35. Kitani A, Hara M, Hirose T, Harigai M, Suzuki K, Kawakami M, Kawaguchi Y, Hidaka T, Kawagoe M, Nakamura T. 1992 Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with systemic lupus erythematosus: analysis of IL-6 production and IL-6R expression. Clin. Exp. Immunol. 88: 75.